We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Balloon Sinuplasty Effective for Treating Chronic Sinusitis

By HospiMedica International staff writers
Posted on 13 Oct 2008
Follow-up studies of balloon sinuplasty patients confirm that sinuplasty technology is safe and effective when used to treat chronic sinusitis patients. More...


Researchers at the Georgia Nasal and Sinus Institute (Savannah, USA) and the Sinus Center of the South (Biloxi, MS, USA) conducted one and two year follow-ups of 109 patients who had minimally invasive sinus surgery using balloon sinuplasty technology that were performed in 2005; all patients had participated previously in the Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR) study. Patients were prospectively evaluated by Sinonasal Outcome Test (SNOT-20) and computed tomographic (CT) scan. The studies found that 92% of the patients had functional patency of the cleared drainage channels at one-year follow-up; at two-year follow-up, 85% of patients reported improvement in their sinus symptoms. No patient's condition worsened, and clinically and statistically significant improvements in their quality of life were maintained at one and two year follow-up. No serious adverse events observed at any time point throughout the studies. Both studies were published in the September 2008 issue of Otolaryngology - Head and Neck Surgery.

"These multi-year data continue to affirm the safety and effectiveness of balloon sinuplasty technology. Patients can feel confident that this technology truly provides significant, durable improvement in sinus symptoms and overall quality of life,” said lead author of the two-year study and co-author of the one-year study, otolaryngologist Raymond Weiss, M.D. of the Sinus Center of the South.

Balloon Sinuplasty technology, developed by Acclarent (Menlo Park, CA, USA) is used to restore normal sinus drainage by widening constricted passages with balloons using an endoscopic, catheter-based system, and can be used alone or in conjunction with standard surgical instrumentation. There is little or no damage to nasal mucosa or to the ostia of the sinus. Recovery times vary after sinus surgery, but patients typically return to normal activities within 24 hours of treatment.

Related Links:
Sinus Center of the South
Acclarent


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Anesthesia Cart
UTGSU-333369-DKB
New
Tracheostomy Tube
Portex BLUselect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The novel AI model boosts early detection and treatment of delirium (Photo courtesy of 123RF)

AI Model Boosts Early Delirium Detection for Improving Health Outcomes of Hospitalized Patients

Delirium, a sudden onset of severe confusion, poses serious life-threatening risks and affects up to one-third of patients in hospitals, often going unnoticed. Without intervention, it can lengthen hospital... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.